Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-10-31 Purchase | 2022-11-02 6:42 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director | 3,625 | $86.75 | $314,469 | 10,905 (Direct) | View |
2021-06-21 Purchase | 2021-06-21 9:14 pm | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 2,000 | $81.34 | $162,680 | 2,000 (Direct) | View |
2020-05-13 Purchase | 2020-05-13 5:05 pm | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 10,000 | $8.859 | $88,590 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-09-16 Exercise | 2023-09-19 4:47 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 2,666 | $0 | 9,000 (Direct) | View |
2023-06-01 Option Award | 2023-06-02 4:22 pm | N/A 2033-05-31 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:23 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director | 4,190 | $0 | 15,095 (Direct) | View |
2022-09-16 Option Award | 2022-09-19 5:08 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-08-17 Disposition | 2022-08-17 4:32 pm | N/A 2031-05-23 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 17,209 | $0 | 0 (Direct) | View |
2022-08-17 Disposition | 2022-08-17 4:32 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 2,000 | $76 | 0 (Direct) | View |
2022-06-01 Option Award | 2022-06-02 7:06 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 17,500 | $0 | 17,500 (Direct) | View |
2022-05-24 Option Award | 2022-05-26 8:12 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director | 4,980 | $0 | 7,280 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 6:09 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director | 2,300 | $0 | 2,300 (Direct) | View |
2021-06-08 Option Award | 2021-06-10 5:24 pm | N/A 2031-06-07 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 17,500 | $0 | 17,500 (Direct) | View |
2021-06-02 Option Award | 2021-06-04 5:34 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 209 | $0 | 209 (Direct) | View |
2021-05-24 Option Award | 2021-05-26 4:50 pm | N/A 2031-05-23 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 17,000 | $0 | 17,000 (Direct) | View |
2020-06-11 Option Award | 2020-06-11 4:51 pm | N/A 2030-06-10 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 17,500 | $0 | 17,500 (Direct) | View |
2019-12-19 Option Award | 2019-12-20 08:14 am | N/A 2029-12-18 | Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director | 35,000 | $0 | 35,000 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Alles Mark J CEO, CHAIRMAN OF BOARD | 145,229 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2022-03-01 | CELGENE CORP | CELG | Alles Mark J CEO, CHAIRMAN OF BOARD | 679,555 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2026-10-31 | CELGENE CORP | CELG | Alles Mark J CEO, CHAIRMAN OF BOARD | 554,328 | $0 | 0 (Direct) | View |